Actavis' presence in India dates back to 2001, when the Group established a sourcing office in the country. Today, Actavis employs more than 620 people in India, who between them deliver a fully integrated and highly cost-effective service.
Possibly the first generic pharmaceutical company from outside India to have a fully integrated operation in the country, Actavis now possesses a full range of services ranging from bio-equivalence studies to stability testing, developing and producing active pharmaceutical ingredients (APIs)—which are the single largest cost component of the business—developing new formulations and producing finished tablet forms.
Actavis Pharma Development
Actavis Pharma Development heads the Group’s strategic plans in India, sourcing active pharmaceutical ingredients (APIs) and finished dosage forms.
The Company is also exploring opportunities for formulation development, clinical trials, contract research and manufacture and new investment prospects in the country.
A strategic collaboration with Emcure Pharmaceuticals and subsequent agreements with other Indian pharmaceutical companies is ensuring a lower cost base for Actavis products in EU and US markets.
In 2005 Actavis acquired Lotus Laboratories, an Indian Contract Research Organisation. Headquartered in Bangalore, Lotus was established in 2001 and employs over 230 people. The company specialises in the management of clinical trials to study the bio-availability and bio-equivalence of drugs, drug-drug interaction and early and late phase clinical trials. Existing clinical facilities have recently been upgraded and new ones established at Chennai and Salem.
Actavis Pharma Development Centre Pvt. Ltd.
No.15, 80 Feet Road
Bangalore 560 095
Tel: +91 80 2563 3097 / 98
Fax:+91 22 2570 6658
Managing Director: G Shankar
Lotus Laboratories Pvt. Ltd.
No.7 Jasma Bhavan Road
Millers Tank Bed Area